- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent Prostate Carcinoma in New Zealand
Total 5786 results
-
Memorial Sloan Kettering Cancer CenterAmbrilia Biopharma, Inc.CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNYU Langone Health; National Institutes of Health (NIH); Weill Medical College... and other collaboratorsCompletedProstate Cancer | Elevated Prostate Specific Antigen (PSA)United States
-
National Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Stage IVA Cervical Cancer AJCC v6 and v7 | Recurrent Cervical Carcinoma | Stage IV Cervical Cancer AJCC v6 and v7 | Stage IVB Cervical Cancer AJCC v6 and v7United States
-
Zenith EpigeneticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous CarcinomaUnited States
-
National Cancer Institute (NCI)AstraZeneca; NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian... and other conditionsUnited States, Canada, Korea, Republic of, Japan
-
Columbia UniversityBristol-Myers Squibb; Ferring PharmaceuticalsActive, not recruiting
-
NYU Langone HealthTerminated
-
NYU Langone HealthCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Beth Israel Medical CenterBayerTerminatedProstate CancerUnited States
-
Columbia UniversityCelgene CorporationCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawn
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Rockefeller UniversityCompletedSafety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells.Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterPSMA Development Corp, LLCCompleted
-
Weill Medical College of Cornell UniversityTerminated
-
NYU Langone HealthCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Weill Medical College of Cornell UniversityCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Weill Medical College of Cornell UniversityTerminatedProstate CancerUnited States
-
Columbia UniversityGenentech, Inc.TerminatedProstate CancerUnited States
-
Matthew GalskyCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
NYU Langone HealthTrod Medical N.V.CompletedProstate CancerUnited States
-
Weill Medical College of Cornell UniversityCompletedProstate CancerUnited States
-
NYU Langone HealthTerminated
-
NYU Langone HealthDendreonTerminatedProstate CancerUnited States
-
Weill Medical College of Cornell UniversityTerminatedProstate CancerUnited States
-
Icahn School of Medicine at Mount SinaiTerminatedProstate CancerUnited States
-
St. Luke's-Roosevelt Hospital CenterTerminatedProstate CancerUnited States
-
NYU Langone HealthNovartisTerminatedProstatic Neoplasms | Prostate CancerUnited States
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
NYU Langone HealthCompletedProstate CancerUnited States
-
Momotaro-Gene Inc.Icahn School of Medicine at Mount SinaiWithdrawn
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx | Recurrent Verrucous Carcinoma of the Oral Cavity | Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage I Squamous Cell Carcinoma of the Oropharynx | Stage I Verrucous... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Nasopharynx Carcinoma | Stage III Nasopharyngeal Carcinoma AJCC v7 | Stage IV Nasopharyngeal Carcinoma AJCC v7 | Stage IVA Nasopharyngeal Carcinoma AJCC v7 | Stage IVB Nasopharyngeal Carcinoma AJCC v7 | Stage IVC Nasopharyngeal Carcinoma AJCC v7 | Nasopharyngeal Nonkeratinizing CarcinomaUnited States, Singapore, China
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedLymphoma | Metastatic Melanoma | Metastatic Renal Cell Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage III Bladder Cancer | Stage IV Bladder Cancer | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm and other conditionsUnited States
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingUnresectable Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Metastatic Breast Adenocarcinoma | Metastatic HER2-Positive Breast Carcinoma | Recurrent Breast Adenocarcinoma | Recurrent HER2-Positive Breast Carcinoma | Unresectable HER2-Positive Breast CarcinomaUnited States, Canada
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Lung Non-Small Cell Squamous Carcinoma | Recurrent Lung Non-Small Cell Carcinoma | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene Mutation | Recurrent Lung Adenocarcinoma | Loss of Heterozygosity | Recurrent... and other conditionsUnited States
-
Dana-Farber Cancer InstituteJanssen Research & Development, LLCActive, not recruitingCastration-resistant Prostate CancerUnited States